Characterization of aerosols generated during patient care activities

Clinical Infectious Diseases

Volumn 65, Issue 8, 2017, Pages 1342-1348

  O'Neil, Caroline A ^a   Li, Jiayu ^b   Leavey, Anna ^b   Wang, Yang ^b   Hink, Matthew ^a   Wallace, Meghan ^c   Biswas, Pratim ^b   Burnham, Carey Ann D ^c   Babcock, Hilary M ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY IN ST LOUIS   (United States)

^c WASHINGTON UNIVERSITY   (United States)

Author keywords

Aerosol generating procedures; Aerosols; Infection prevention

Indexed keywords

BIOLOGICAL PRODUCT;

AEROSOL; ARTICLE; BACTERIUM CULTURE; BRONCHOSCOPY; CONCENTRATION (PARAMETERS); DISEASE TRANSMISSION; FLUSHING; HEALTH CARE PERSONNEL; INFECTIOUS AGENT; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NEBULIZATION; NONINVASIVE VENTILATION; PARTICLE SIZE; PATIENT CARE; PRIORITY JOURNAL; VANCOMYCIN RESISTANT ENTEROCOCCUS; ANALYSIS; BACTERIUM; ENVIRONMENTAL MICROBIOLOGY; ENVIRONMENTAL MONITORING; HUMAN; INFECTION CONTROL; ISOLATION AND PURIFICATION; PROCEDURES; STANDARDS;

AEROSOLS; BACTERIA; ENVIRONMENTAL MICROBIOLOGY; ENVIRONMENTAL MONITORING; HUMANS; INFECTION CONTROL; PARTICLE SIZE; PATIENT CARE;

EID: 85032784699     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cix535     Document Type: Article

References (37)

1. Coia JE, Ritchie L, Adisesh A, et al; Healthcare Infection Society Working Group on Respiratory and Facial Protection. Guidance on the use of respiratory and facial protection equipment. J Hosp Infect 2013; 85:170-82.
2. Centers for Disease Control and Prevention. Interim guidance on infection control measures for 2009 H1N1 influenza in healthcare settings, including protection of healthcare personnel. Available at: http://www.cdc.gov/h1n1flu/guidelines-infection-control.htm. Accessed 10 August 2016.
3. Centers for Disease Control and Prevention. Prevention strategies for seasonal influenza in healthcare settings. Available at: http://www.cdc.gov/flu/professionals/infectioncontrol/healthcaresettings.htm. Accessed 10 June 2015.
4. World Health Organization. Infection prevention and control in health care for confirmed or suspected cases of pandemic (H1N1) 2009 and influenza-like illnesses. Available at: http://www.who.int/csr/resources/publications/cp150-2009-1612-ipc-interim-guidance-h1n1.pdf?ua=1. Accessed 8 August 2016.
5. Chughtai AA, Seale H, MacIntyre CR. Availability, consistency and evidence-base of policies and guidelines on the use of mask and respirator to protect hospital health care workers: a global analysis. BMC Res Notes 2013; 6:216.
6. Gralton J, McLaws ML. Protecting healthcare workers from pandemic influenza: N95 or surgical masks? Crit Care Med 2010; 38:657-67.
7. World Health Organization. Infection prevention and control of epidemic-and pandemic-prone acute respiratory infections in health care: WHO guidelines. Geneva, Switzerland: WHO, 2014.
8. Siegel JD, Rhinehart E, Jackson M, Chiarello L; Health Care Infection Control Practices Advisory Committee. 2007 guideline for isolation precautions: preventing transmission of infectious agents in health care settings. Am J Infect Control 2007; 35:S65-164.
9. McCracken J. Should noninvasive ventilation be considered a high-risk procedure during an epidemic? CMAJ 2009; 181:663-4.
10. Christian MD, Loutfy M, McDonald LC, et al; SARS Investigation Team. Possible SARS coronavirus transmission during cardiopulmonary resuscitation. Emerg Infect Dis 2004; 10:287-93.
11. Fowler RA, Lapinsky SE, Hallett D, et al; Toronto SARS Critical Care Group. Critically ill patients with severe acute respiratory syndrome. JAMA 2003; 290:367-73.
12. Ofner M, Lem M, Sarwal S, Vearncombe M, Simor A. Cluster of severe acute respiratory syndrome cases among protected health care workers - Toronto, April 2003. Can Commun Dis Rep 2003; 29:93-7.
13. Centers for Disease Control and Prevention. Infection control precautions for aerosol-generating procedures on patients who have suspected severe acute respiratory syndrome (SARS). Atlanta, GA: CDC, 2013.
14. Hui DS. Severe acute respiratory syndrome (SARS): lessons learnt in Hong Kong. J Thorac Dis 2013; 5(SUPPL. 2):S122-6.
15. Booth TF, Kournikakis B, Bastien N, et al. Detection of airborne severe acute respiratory syndrome (SARS) coronavirus and environmental contamination in SARS outbreak units. J Infect Dis 2005; 191:1472-7.
16. Kuster SP, Coleman BL, Raboud J, et al. Risk factors for influenza among health care workers during 2009 pandemic, Toronto, Ontario, Canada. Emerg Infect Dis 2013; 19:606-15.
17. Tellier R. Aerosol transmission of influenza A virus: a review of new studies. J R Soc Interface 2009; 6(SUPPL. 6):S783-90.
18. Lindsley WG, Blachere FM, Davis KA, et al. Distribution of airborne influenza virus and respiratory syncytial virus in an urgent care medical clinic. Clin Infect Dis 2010; 50:693-8.
19. Al-Dorzi HM, Alsolamy S, Arabi YM. Critically ill patients with Middle East respiratory syndrome coronavirus infection. Crit Care 2016; 20:65.
20. Al-Tawfiq JA, Perl TM. Middle East respiratory syndrome coronavirus in healthcare settings. Curr Opin Infect Dis 2015; 28:392-6.
21. Mekibib B, Arien KK. Aerosol transmission of filoviruses. Viruses 2016; 8:148.
22. Eames I, Tang J W, Li Y, Wilson P. Airborne transmission of disease in hospitals. J R Soc Interface 2009; 6(SUPPL. 6):S697-702.
23. Davies A, Thompson G, Walker J, Bennett A. A review of the risks and disease transmission associated with aerosol generating medical procedures. J Infect Prev 2009; 10:122-6.
24. Tran K, Cimon K, Severn M, Pessoa-Silva CL, Conly J. Aerosol generating procedures and risk of transmission of acute respiratory infections to healthcare workers: a systematic review. PLoS One 2012; 7:e35797.
25. Gamage B, Moore D, Copes R, Yassi A, Bryce E; BC Interdisciplinary Respiratory Protection Study Group. Protecting health care workers from SARS and other respiratory pathogens: a review of the infection control literature. Am J Infect Control 2005; 33:114-21.
26. Branda JA, Rychert J, Burnham CA, et al. Multicenter validation of the VITEK MS v2.0 MALDI-TOF mass spectrometry system for the identification of fastidious gram-negative bacteria. Diagn Microbiol Infect Dis 2014; 78:129-31.
27. Manji R, Bythrow M, Branda JA, et al. Multi-center evaluation of the VITEK MS system for mass spectrometric identification of non-Enterobacteriaceae gram-negative bacilli. Eur J Clin Microbiol Infect Dis 2014; 33:337-46.
28. Richter SS, Sercia L, Branda JA, et al. Identification of Enterobacteriaceae by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry using the VITEK MS system. Eur J Clin Microbiol Infect Dis 2013; 32: 1571-8.
29. McElvania TeKippe E, Burnham CA. Evaluation of the bruker biotyper and VITEK MS MALDI-TOF MS systems for the identification of unusual and/or difficult-to-identify microorganisms isolated from clinical specimens. Eur J Clin Microbiol Infect Dis 2014; 33:2163-71.
30. Wang Y, Li J, Leavey A, O'Neil C, Babcock HM, Biswas P. Comparative study on the size distributions, respiratory deposition, and transport of particles generated from commonly used medical nebulizers. J Aerosol Med Pulm Drug Deliv 2016; 30:132-40.
31. Zhang Y, Seale H, Yang P, et al. Factors associated with the transmission of pandemic (H1N1) 2009 among hospital healthcare workers in Beijing, China. Influenza Other Respir Viruses 2013; 7:466-71.
32. Seto WH. Airborne transmission and precautions: facts and myths. J Hosp Infect 2015; 89:225-8.
33. Thompson KA, Pappachan J V, Bennett AM, et al. Influenza aerosols in UK hospitals during the H1N1 (2009) pandemic - the risk of aerosol generation during medical procedures. PLoS One 2013; 8:e56278.
34. Esquinas AM, Egbert Pravinkumar S, Scala R, et al; International NIV Network. Noninvasive mechanical ventilation in high-risk pulmonary infections: a clinical review. Eur Respir Rev 2014; 23:427-38.
35. Johnson DL, Mead KR, Lynch RA, Hirst D V. Lifting the lid on toilet plume aerosol: a literature review with suggestions for future research. Am J Infect Control 2013; 41:254-8.
36. Simonds AK, Hanak A, Chatwin M, et al. Evaluation of droplet dispersion during non-invasive ventilation, oxygen therapy, nebuliser treatment and chest physiotherapy in clinical practice: implications for management of pandemic influenza and other airborne infections. Health Technol Assess 2010; 14:131-72.
37. Kesavan J, Schepers D, McFarland AR. Sampling and retention efficiencies of batch-type liquid-based bioaerosol samplers. Aerosol Sci Tech 2010; 44:817-29.